Royalty Pharma Plc Cash Flow Quality Index
Royalty Pharma Plc cash flow quality index. Royalty Pharma Plc (RPRX) has a Cash Flow Quality Index of 2.58x as of March 2026. Operating cash flow of $760.54 Million exceeds net income of $294.69 Million, indicating high earnings quality where cash backs reported profits. Explore Royalty Pharma Plc (RPRX) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Royalty Pharma Plc (2017–2025)
Cash flow quality index of Royalty Pharma Plc from 2017 to 2025. Historical Cash Flow Quality Index for Royalty Pharma Plc across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. See Royalty Pharma Plc (RPRX) balance sheet quality index to measure how much of total assets are equity-financed.
Royalty Pharma Plc Cash Flow Quality Index by Year (2017–2025)
Royalty Pharma Plc cash flow quality index by year from 2017 to 2025. Year-by-year earnings quality comparison for Royalty Pharma Plc. For the full cash flow conversion analysis, see cash efficiency ratio of Royalty Pharma Plc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.88x | $2.49 Billion | $1.32 Billion | ▼ -9.6% |
| 2024 | 2.08x | $2.77 Billion | $1.33 Billion | ▲ +18.4% |
| 2023 | 1.76x | $2.99 Billion | $1.70 Billion | ▼ -81.1% |
| 2022 | 9.32x | $2.14 Billion | $230.06 Million | ▲ +473.3% |
| 2021 | 1.63x | $2.02 Billion | $1.24 Billion | ▲ +36.0% |
| 2020 | 1.20x | $2.03 Billion | $1.70 Billion | ▲ +76.5% |
| 2019 | 0.68x | $1.67 Billion | $2.46 Billion | ▼ -36.5% |
| 2018 | 1.07x | $1.62 Billion | $1.52 Billion | ▲ +1.0% |
| 2017 | 1.06x | $1.42 Billion | $1.34 Billion | — |